Evelo Biosciences Presents New Preclinical Data for Extracellular Vesicle Anti-inflammatory Product Candidate EDP2939 at the American Association of Immunologists Meeting
–On-track to initiate clinical development of EDP2939 in 2022– CAMBRIDGE, Mass., May 13, 2021 (GLOBE…
More than 1,000 top buyers to attend! Procurement opportunities at China Chaoshan International Textile and Garment Exhibition
Axonex Intelligence and Synergy Technology Group Form Joint Venture to Accelerate Digital Twin and Drone Flight Control Expansion
Yuexiu REIT Maintains Operational Resilience, Revenue Exceeds RMB1.8 Billion in 2025
MarketingPulse and eTailingPulse open next Thursday
Inverite Reports Continued Strong 2026 Growth and Record Monthly Performance in February